HBMCX
Price
$20.58
Change
+$0.14 (+0.68%)
Updated
Aug 21 closing price
Net Assets
690.59M
RPTIX
Price
$103.59
Change
+$0.77 (+0.75%)
Updated
Aug 21 closing price
Net Assets
22.65B
Interact to see
Advertisement

HBMCX vs RPTIX

HBMCX vs RPTIX Comparison Chart in %
View a ticker or compare two or three
VS
HBMCX vs. RPTIX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBMCX is a StrongBuy and RPTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 22.6B vs. HBMCX (691M). RPTIX pays higher dividends than HBMCX: RPTIX (0.11) vs HBMCX (0.00). HBMCX was incepted earlier than RPTIX: HBMCX (27 years) vs RPTIX (11 years). HBMCX (1.01) is less costly to investors than RPTIX (0.63). HBMCX is a more actively managed with annual turnover of: 60.00 vs. RPTIX (31.50). HBMCX has a lower initial minimum investment than RPTIX: HBMCX (0) vs RPTIX (500000). RPTIX annual gain was more profitable for investors over the last year : 1.78 vs. HBMCX (-24.39). RPTIX return over 5 years is better than : -17.83 vs. HBMCX (-53.12).
HBMCXRPTIXHBMCX / RPTIX
Total Expense Ratio1.010.63160%
Annual Report Gross Expense Ratio1.010.63160%
Fund Existence27 years11 years-
Gain YTD-3.1536.148-51%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets691M22.6B3%
Annual Yield % from dividends0.000.11-
Returns for 1 year-24.391.78-1,370%
Returns for 3 years-18.855.65-334%
Returns for 5 years-53.12-17.83298%
Returns for 10 years-41.4533.21-125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRITX24.100.23
+0.96%
T. Rowe Price International Stock
DCSYX76.250.40
+0.53%
Davis Balanced Fund Y
SZCCX43.110.19
+0.44%
DWS Small Cap Core C
PDRDX14.090.06
+0.43%
Principal Diversified Real Asset Instl
IGFSX7.33N/A
N/A
Voya Global Equity Insights Portfolio S2